|
Volumn 20, Issue 4, 2005, Pages 42-44
|
CDC releases detailed guidelines for PEP use. Agency focuses on nonoccupational exposure.
[No Author Info available]
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;
ARTICLE;
DISEASE TRANSMISSION;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
PATIENT COMPLIANCE;
PRACTICE GUIDELINE;
PUBLIC HEALTH SERVICE;
UNITED STATES;
ANTI-HIV AGENTS;
CENTERS FOR DISEASE CONTROL AND PREVENTION (U.S.);
HIV INFECTIONS;
HUMANS;
PATIENT COMPLIANCE;
PRACTICE GUIDELINES;
UNITED STATES;
|
EID: 17144418076
PISSN: 08870292
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (1)
|
References (0)
|